Lacosamide is a novel NMDA receptor glycine site binding antagonist, belonging to a new class of functional amino acids, and an anticonvulsant drug with a new dual mechanism of action. It can selectively promote the slow inactivation of sodium channels and regulate collapse response mediator protein-2 (CRMP-2), which may slow down or even prevent epileptic seizures and alleviate diabetic neuropathic pain.
Brand: Soarwin
CAS No.:175481-36-4
EC Number:239-055-2
Molecular Formula:C13H18N2O3
Density: 1.0247 (rough estimate)
Melting point:158-162°C
Boiling point: 154°C (rough estimate)
Flash point:211°C
